
Dr Michael O'Callaghan
Senior Lecturer
Adelaide Medical School
Faculty of Health and Medical Sciences
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
- My Research
- Career
- Publications
- Grants and Funding
- Teaching
- Supervision
- Professional Activities
- Contact
I am a clinical epidemiologist with expertise in:
- Prostate Cancer
- Urology
- Clinical Registries
- Evidence Based Medicine
-
Appointments
Date Position Institution name 2020 - ongoing Associate Professor Flinders University 2016 - ongoing Affiliate Senior Lecturer University of Adelaide 2015 - 2020 Affiliate Senior Lecturer Flinders University 2014 - 2016 Visiting Research Fellow University of Adelaide 2013 - ongoing Senior Researcher and Educator SA Health 2013 - 2016 Honorary Affiliate Lecturer University of Adelaide, Robinson Institute 2013 - 2013 Postdoctoral Research Fellow University of South Australia 2012 - 2013 Postdoctoral Research Fellow University of Adelaide 2011 - 2012 Endeavour Postdoctoral Research Fellow University of Auckland -
Education
Date Institution name Country Title 2004 University of Adelaide, Department of Physiology Australia Honours Degree of Science 2003 University of Adelaide, Department pf Physiology Australia Bachelor Degree of Science -
Postgraduate Training
Date Title Institution Country 2008 - 2011 PhD candidate with the Discipline of Obstetrics and Gynaecology University of Adelaide, Faculty of Health and Medical Sciences Australia -
Certifications
Date Title Institution name Country 2019 Statistical Practice in Epidemiology using R University of Tartu Estonia 2018 Postgraduate Research Supervision Program Flinders University Australia 2018 Good Clinical Practice NIDA Clinical Trials Network 2013 Epidemiological Methods International Epidemiological Association China 2012 Analysis of Linked Data Statistical Society of Australia 2009 Future Research Leaders Program Go8 Universities of Australia 2008 Cochrane Review methods Australasian Cochrane Centre -
Research Interests
-
Journals
Year Citation 2022 David, R., Buckby, A., Kahokehr, A. A., Lee, J., Watson, D. I., Leung, J., & O’Callaghan, M. E. (2022). Long term genitourinary toxicity following curative intent intensity-modulated radiotherapy for prostate cancer: a systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases, 8 pages.
WoS12021 Soo, A., O’Callaghan, M. E., Kopsaftis, T., Vatandoust, S., Moretti, K., & Kichenadasse, G. (2021). PSA response to antiandrogen withdrawal: a systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases, 24(3), 826-836.
Scopus2 WoS2 Europe PMC22021 O’Callaghan, M., Papa, N., Pase, M., Frydenberg, M., Mark, S., Moretti, K., . . . Millar, J. (2021). Patterns of care for prostate cancer treatment and improving outcomes – are national registries the answer?. BJU International, 128(S1), 6-8.
Scopus1 WoS12021 Jay, A. P. M., Aldiwani, M., O'Callaghan, M. E., Pearce, A. K., Huddart, R. A., Mayer, E., . . . Nicol, D. L. (2021). Features and Management of Late Relapse of Nonseminomatous Germ Cell Tumour. European Urology Open Science, 29, 82-88.
Scopus1 WoS12021 Kinnear, N., Jolly, S., Herath, M., Han, J., Tran, M., O'Callaghan, M., . . . Moore, J. (2021). The acute surgical unit: An updated systematic review and meta-analysis. International Journal of Surgery, 94(October), 1-13.
2021 Pryor, D. I., Martin, J. M., Millar, J. L., Day, H., Ong, W. L., Skala, M., . . . Papa, N. (2021). Evaluation of Hypofractionated Radiation Therapy Use and Patient-Reported Outcomes in Men with Nonmetastatic Prostate Cancer in Australia and New Zealand. JAMA Network Open, 4(11), 12 pages.
2020 Lu, T. C., Collins, L., Cohen, P., Jay, A., Campbell, J. M., & O’Callaghan, M. (2020). Prognostic Differences in ISUP Grade Group 4: a Systematic Review and Meta-Analysis. Pathology and Oncology Research, 26(3), 1367-1375.
Scopus4 WoS3 Europe PMC22020 Kinnear, N., Barnett, D., O'Callaghan, M., Horsell, K., Gani, J., & Hennessey, D. (2020). The impact of catheter-based bladder drainage method on urinary tract infection risk in spinal cord injury and neurogenic bladder: A systematic review. Neurourology and Urodynamics, 39(2), 854-862.
Scopus12 WoS11 Europe PMC12020 Jones, B. C., Youlden, D. R., Cundy, T. P., O'Callaghan, M. E., Karpelowsky, J., Aitken, J. F., & McBride, C. A. (2020). Renal tumours in Australian children: 30 years of incidence, outcome and second primary malignancy data from the Australian Childhood Cancer Registry. Journal of Paediatrics and Child Health, 56(6), 908-916.
Scopus1 WoS1 Europe PMC12020 Lin, D., O'Callaghan, M., David, R., Fuller, A., Wells, R., Sutherland, P., & Foreman, D. (2020). Does urethral length affect continence outcomes following robot assisted laparoscopic radical prostatectomy (RALP)?. BMC Urology, 20(1), 7 pages.
Scopus8 WoS8 Europe PMC12020 Morias, S., Buckley, E., Beckmann, K., O'Callaghan, M., Borg, M., & Short, M. (2020). Variation in radiotherapy patterns of care in the radical treatment of South Australian men with non-metastatic prostate cancer between 2005–2015. Radiotherapy and Oncology, 145, 138-145.
2020 Tempo, J., Logan, C., O'Callaghan, M., Kahokehr, A., Kichenadasse, G., D'Onise, K., & Foreman, D. (2020). Bladder, penile, renal pelvis and testis cancers: A population based analysis of incidence and survival 1977-2013. Cancer Epidemiology, 65, 8 pages.
Scopus2 WoS3 Europe PMC22020 John, A., O'Callaghan, M., Catterwell, R., & Selth, L. (2020). Does Gleason score of positive surgical margin after radical prostatectomy affect biochemical recurrence and oncological outcomes? Protocol for systematic review. BMJ Open, 10(3), 4 pages.
Scopus1 WoS12020 Kinnear, N., Herath, M., Jolly, S., Han, J., Tran, M., Parker, D., . . . Moore, J. (2020). Patient Satisfaction in Emergency General Surgery: A Prospective Cross-Sectional Study. World J Surg, 44(9), 2950-2958.
Scopus3 WoS3 Europe PMC12020 Ang, M., Borg, M., & O'Callaghan, M. E. (2020). Survival outcomes in men with a positive family history of prostate cancer: A registry based study. BMC Cancer, 20(1), 8 pages.
Scopus3 WoS4 Europe PMC22020 O'Callaghan, M. E., Jay, A., Kichenadasse, G., & Moretti, K. L. (2020). Androgen deprivation therapy in unlikely to be effective for treatment of COVID-19. Annals of Oncology, 31(12), 1780-1782.
Scopus5 WoS4 Europe PMC32019 Beckmann, K., O'Callaghan, M., Vincent, A., Cohen, P., Borg, M., Roder, D., . . . Moretti, K. (2019). Extent and predictors of grade upgrading and downgrading in an Australian cohort according to the new prostate cancer grade groupings.. Asian journal of urology, 6(4), 321-329.
Scopus5 Europe PMC42019 Forgione, M., Sara, S., Vincent, A. D., Borg, M., Moretti, K., & O'Callaghan, M. E. (2019). Satisfaction with care in men with prostate cancer. European Journal of Cancer Care, 28(4), e13028-1-e13028-8.
Scopus4 WoS4 Europe PMC12019 Kinnear, N., O'Callaghan, M., Hennessey, D., Liddell, H., Newell, B., Bolt, J., & Lawrentschuk, N. (2019). Intra-operative cell salvage in urological surgery: a systematic review and meta-analysis of comparative studies. BJU International, 123(2), 210-219.
Scopus7 WoS8 Europe PMC32018 Aref, A., Vincent, A. D., O'Callaghan, M., Martin, S., Sutherland, P., Hoy, A., . . . Wittert, G. (2018). The inverse relationship between prostate specific antigen (PSA) and obesity. Endocrine-Related Cancer, 25(11), 933-941.
Scopus11 WoS10 Europe PMC82018 Neumann, P. B., & O'Callaghan, M. (2018). The role of preoperative puborectal muscle function assessed by transperineal ultrasound in urinary continence outcomes at 3, 6, and 12 months after robotic-assisted radical prostatectomy. International Neurourology Journal, 22(2), 114-122.
Scopus9 WoS9 Europe PMC22018 Burdett, N., Vincent, A., O'Callaghan, M., & Kichenadasse, G. (2018). Competing risks in older patients with cancer: A systematic review of geriatric oncology trials. Journal of the National Cancer Institute, 110(8), 825-830.
Scopus10 WoS11 Europe PMC72018 Lu, T. C., Moretti, K., Beckmann, K., Cohen, P., & O Callaghan, M. (2018). ISUP Group 4 – a Homogenous Group of Prostate Cancers?. Pathology and Oncology Research, 24(4), 921-925.
Scopus5 Europe PMC12018 Moretti, K. L., Shi, Z., Kopsaftis, T., & O’Callaghan, M. E. (2018). Delays in radical prostatectomy for prostate cancer and survival outcomes. World Journal of Urology, 36(8), 1337-1338.
2018 Vatandoust, S., Kichenadasse, G., O'Callaghan, M., Vincent, A., Kopsaftis, T., Walsh, S., . . . Moretti, K. (2018). Localized prostate cancer in elderly men aged 80-89, findings from a population-based registry.. BJU international, 121(S3), 48-54.
Scopus9 WoS10 Europe PMC42018 Moretti, K., Vatandoust, S., Kichenadasse, G., O’callaghan, M. E., Vincent, A. D., Kopsaftis, T., . . . Karapetis, C. (2018). Prostate cancer mortality is high in the elderly and can be reduced by selective individualized curative treatment. World Journal of Urology, 36(11), 1799-1800.
Scopus1 WoS1 Europe PMC12018 Hoffmann, R., Logan, C., O Callaghan, M., Gormly, K., Chan, K., & Foreman, D. (2018). Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)?. International Urology and Nephrology, 50(1), 13-19.
Scopus11 WoS9 Europe PMC82018 Beckmann, K., O'Callaghan, M., Vincent, A., Roder, D., Millar, J., Evans, S., . . . Moretti, K. (2018). Australian validation of the Cancer of the Prostate Risk Assessment Post-Surgical score to predict biochemical recurrence after radical prostatectomy. ANZ Journal of Surgery, 88(3), E183-E188.
Scopus2 WoS22017 Campbell, J., O'Callaghan, M., Raymond, E., Vincent, A., Beckmann, K., Roder, D., . . . Moretti, K. (2017). Tools for Predicting Clinical and Patient-reported Outcomes in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy: A Systematic Review of Prognostic Accuracy and Validity. Clinical Genitourinary Cancer, 15(6), 629-634.
Scopus5 WoS3 Europe PMC32017 O'Callaghan, M., Raymond, E., Campbell, J., Vincent, A., Beckmann, K., Roder, D., . . . Moretti, K. (2017). Tools for predicting patient-reported outcomes in prostate cancer patients undergoing radical prostatectomy: A systematic review of prognostic accuracy and validity. Prostate Cancer and Prostatic Diseases, 20(4), 378-388.
Scopus14 WoS12 Europe PMC72017 O'Callaghan, M. E., Raymond, E., Campbell, J. M., Vincent, A. D., Beckmann, K., Roder, D., . . . Moretti, K. (2017). Patient-reported outcomes after radiation therapy in men with prostate cancer: a systematic review of prognostic tool accuracy and validity. International Journal of Radiation Oncology Biology Physics, 98(2), 318-337.
Scopus10 WoS8 Europe PMC62017 Beckmann, K., O'Callaghan, M., Ruseckaite, R., Kinnear, N., Miller, C., Evans, S., . . . Moretti, K. (2017). Prostate cancer outcomes for men who present with symptoms at diagnosis. BJU International, 119(6), 862-871.
Scopus5 WoS5 Europe PMC32017 O’Callaghan, M. E., Shi, Z., Kopsaftis, T., & Moretti, K. (2017). Prostate cancer outcomes and delays in care. International Urology and Nephrology, 49(3), 449-455.
Scopus8 WoS9 Europe PMC62017 Raymond, E., O'Callaghan, M., Campbell, J., Vincent, A., Beckmann, K., Roder, D., . . . Moretti, K. (2017). An appraisal of analytical tools used in predicting clinical outcomes following radiation therapy treatment of men with prostate cancer: a systematic review. Radiation Oncology, 12(1), 56-1-56-20.
Scopus12 WoS10 Europe PMC32017 Beckmann, K., Vincent, A., O'Callaghan, M., Cohen, P., Chang, S., Borg, M., . . . Moretti, K. (2017). Oncological outcomes in an Australian cohort according to the new prostate cancer grading groupings. BMC cancer, 17(1), 537.
Scopus2 WoS12017 Campbell, J., Raymond, E., O'Callaghan, M., Vincent, A., Beckmann, K., Roder, D., . . . Moretti, K. (2017). Optimum Tools for Predicting Clinical Outcomes in Prostate Cancer Patients Undergoing Radical Prostatectomy: A Systematic Review of Prognostic Accuracy and Validity. Clinical Genitourinary Cancer, 15(5), e827-e834.
Scopus10 WoS12 Europe PMC42016 Ruseckaite, R., Beckmann, K., O'Callaghan, M., Roder, D., Moretti, K., Millar, J., & Evans, S. (2016). A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: Trends in clinical presentation and management of the disease. BMC Cancer, 16(1), 11 pages.
Scopus17 WoS15 Europe PMC82016 Ruseckaite, R., Beckmann, K., O'Callaghan, M., Roder, D., Moretti, K., Zalcberg, J., . . . Evans, S. (2016). Development of South Australian-Victorian Prostate Cancer Health Outcomes Research Dataset. BMC Research Notes, 9(1), 37.
Scopus4 Europe PMC32016 Ang, M., Rajcic, B., Foreman, D., Moretti, K., & O'Callaghan, M. (2016). Men presenting with prostate-specific antigen (PSA) values of over 100 ng/mL. BJU international, 117(Suppl. 4), 68-75.
Scopus13 WoS16 Europe PMC112016 Kinnear, N., Kichenadasse, G., Plagakis, S., O'Callaghan, M., Kopsaftis, T., Walsh, S., & Foreman, D. (2016). Prostate cancer in men aged less than 50 years at diagnosis. World Journal of Urology, 34(11), 1533-1539.
Scopus18 WoS16 Europe PMC142015 Roberts, R., Miller, M., O'Callaghan, M., & Koczwara, B. (2015). Bone health management of Australian breast cancer survivors receiving hormonal therapy. Internal Medicine Journal, 45(11), 1182-1185.
Scopus2 WoS1 Europe PMC12015 McMichael, G., Bainbridge, M., Haan, E., Corbett, M., Gardner, A., Thompson, S., . . . MacLennan, A. (2015). Whole-exome sequencing points to considerable genetic heterogeneity of cerebral palsy. Molecular Psychiatry, 20(2), 176-182.
Scopus112 WoS96 Europe PMC712015 O'Callaghan, M. (2015). Cancer risk: accuracy of literature. Science, 347(6223), 729.
Scopus22 WoS19 Europe PMC142015 O'Callaghan, M., Kichenadasse, G., Vatandoust, S., & Moretti, K. (2015). Informed decision making about prostate cancer screening. Annals of Internal Medicine, 162(6), 457.
Scopus1 WoS12015 Plagakis, S., Edwards, S., O'Callaghan, M., & Foreman, D. (2015). Predicting bladder cancer death amongst Australian Veterans. Journal of Military and Veterans' Health, 23(1), 4-9. 2013 O'Callaghan, M., & MacLennan, A. (2013). Cesarean delivery and cerebral palsy: A systematic review and meta-analysis. Obstetrics and Gynecology, 122(6), 1169-1175.
Scopus34 WoS31 Europe PMC192013 O'Callaghan, M., MacLennan, A., McMichael, G., Haan, E., & Dekker, G. (2013). Single-nucleotide polymorphism associations with preterm delivery: a case-control replication study and meta-analysis. Pediatric Research, 74(4), 433-438.
Scopus7 WoS5 Europe PMC42013 O'Callaghan, M., MacLennan, A., Gibson, C., McMichael, G., Haan, E., Broadbent, J., . . . Dekker, G. (2013). Genetic and clinical contributions to cerebral palsy: A multi-variable analysis. Journal of Paediatrics and Child Health, 49(7), 575-581.
Scopus11 WoS5 Europe PMC52013 O'Callaghan, M., & MacLennan, A. (2013). Brain damage and maternal medication. American Journal of Obstetrics and Gynecology, 208(2), 160-161.
2013 O'Callaghan, M. (2013). Apolipoprotein E and the genetics of cerebral palsy - where to next?. Developmental Medicine and Child Neurology, 55(4), 302-303.
2012 O'Callaghan, M., MacLennan, A., Gibson, C., McMichael, G., Haan, E., Broadbent, J., . . . Dekker, G. (2012). Fetal and maternal candidate single nucleotide polymorphism associations with Cerebral Palsy: a case-control study. Pediatrics, 129(2), E414-E423.
Scopus31 WoS22 Europe PMC172011 O'Callaghan, M., MacLennan, A., Gibson, C., McMichael, G., Haan, E., Broadbent, J., . . . Dekker, G. (2011). Epidemiologic associations with cerebral palsy. Obstetrics and Gynecology, 118(3), 576-582.
Scopus79 WoS75 Europe PMC462011 McMichael, G., Highet, A., Gibson, C., Goldwater, P., O'Callaghan, M., Alvino, E., & MacLennan, A. (2011). Comparison of DNA extraction methods from small samples of newborn screening cards suitable for retrospective perinatal viral research. Journal of Biomolecular Techniques, 22(1), 5-9.
Scopus6 Europe PMC42011 O'Callaghan, M., MacLennan, A., Gibson, C., McMichael, G., Haan, E., Broadbent, J., . . . Dekker, G. (2011). The Australian cerebral palsy research study - Protocol for a national collaborative study investigating genomic and clinical associations with cerebral palsy. Journal of Paediatrics and Child Health, 47(3), 99-110.
Scopus11 WoS9 Europe PMC62010 Kremmidiotis, G., Leske, A., Lavranos, T., Beaumont, D., Gasic, J., Hall, A., . . . Flynn, B. (2010). BNC105: a novel tubulin polymerization inhibitor that selectively disrupts tumor vasculature and displays single-agent antitumor efficacy. Molecular Cancer Therapeutics, 9(6), 1562-1573.
Scopus70 WoS64 Europe PMC402009 McMichael, G., Gibson, C., O'Callaghan, M., Goldwater, P., Dekker, G., Haan, E., & MacLennan, A. (2009). DNA from Buccal Swabs Suitable for High-Throughput SNP Multiplex Analysis. Journal of Biomolecular Techniques, 20(5), 232-235.
Scopus25 Europe PMC182009 O'Callaghan, M., MacLennan, A., Haan, E., & Dekker, G. (2009). The genomic basis of cerebral palsy: A HuGE systematic literature review. Human Genetics, 126(1), 149-172.
Scopus46 WoS38 Europe PMC34Lin, D., O'Callaghan, M. E., David, R., Fuller, A., Wells, R., Sutherland, P., & Foreman, D. (n.d.). Does urethral length affect continence outcomes following robot assisted laparoscopic radical prostatectomy (RALP)?.
Lin, D., O'Callaghan, M. E., David, R., Fuller, A., Wells, R., Sutherland, P., & Foreman, D. (n.d.). Does urethral length affect continence outcomes following robot assisted laparoscopic radical prostatectomy (RALP)?.
-
Conference Papers
Year Citation 2019 Forgione, M., Sara, S., Vincent, A. D., Borg, M., Moretti, K., & O'Callaghan, M. E. (2019). Satisfaction with care in men with prostate cancer. In Abstracts of the 2nd Prostate Cancer World Congress (PCWC 2015), as published in BJU International Vol. 116 (pp. 22-23). Cairns, AUSTRALIA: Wiley.
2010 O'Callaghan, M. E., MacLennan, A. H., Goldwater, P. N., McMichael, G., & et al. (2010). Australian Collaborative Study of genomic and environmental factors associated with CP. In Conference Proceedings. Sydney, Australia. -
Conference Items
Funding and Awards
Grants
Year | Grant | CI's / PI's | Amount |
---|---|---|---|
2021 | Infrastructure grant – SA-PCCOC – The Hospital Research Foundation. | K Moretti, M O’Callaghan | |
2020 | SA Prostate Cancer Outcomes Registry – Movember Foundation ( | K Moretti, M O’Callaghan | |
2019 | Beat Cancer Infrastructure Grant - Prostate Cancer in South Australia – Improving Quality Treatment and Accelerating Research | K Moretti, M O’Callaghan | |
2019 | SA Prostate Cancer Outcomes Registry – Movember Foundation | K Moretti; AIs: M O’Callaghan, S Walsh, T Kopsaftis | |
2019 | Predicting Urinary Incontinence and Erectile Dysfunction after Prostate Cancer Surgery. - Movember Clinical Quality Improvement Research Program | K Moretti, M O’Callaghan, A Vincent, K Beckmann, D Smith, S Mark, M Frydenberg, S Evans, J Clarke, S Walsh, T Kopsaftis, M Evans, D Merry. | |
2019 | Evaluating the benefits, harms and cost-effectiveness of variation in compliance with best practice guidelines for the treatment of localised prostate cancer – Movember Clinical Quality Improvement Research Program | D Smith, M Patel, S Sengupta, I Vela, A Kneebone, H Woo, S Evans, M O’Callaghan, D Cancian, K Canfell, K Chiam, M Caruana. | |
2018 | SA Prostate Cancer Outcomes Registry – Movember Foundation | K Moretti; AIs: M O’Callaghan, S Walsh, T Kopsaftis | |
2018 | Beat Cancer Infrastructure Grant - Prostate Cancer in South Australia – Improving Quality Treatment and Accelerating Research | K Moretti, M O’Callaghan | |
2018 | 2018/19 Below the Belt Research Fund - Why do men leave active surveillance? A mixed methods investigation examining factors contributing to adherence on active surveillance. | Camile Short; AIs: M McIntosh, M Opozda, D Galvao, A Vincent, M O’Callaghan. | |
2018 | 2018 Clinical project grant – Royal Adelaide Hospital - Influence of obesity and lipid abnormalities on prostate cancer aggressiveness among men treated for prostate cancer at the Royal Adelaide Hospital | P Sutherland; AIs: A Aref, L Butler, G Wittert, A Vincent, M O’Callaghan | |
2017 | SA Prostate Cancer Outcomes Registry – Movember Foundation | K Moretti; AIs: M O’Callaghan, S Walsh, T Kopsaftis | |
2017 |
SA Prostate Cancer Outcomes Registry – The Hospital Research Foundation | K Moretti; AIs: M O’Callaghan, S Walsh, T Kopsaftis |
Awards
Year | Award |
---|---|
2018 | Shortlisted for the 2018 Flinders Centre for Innovation in Cancer HDR Supervisor Award |
Teaching and Mentorship
Urology Registrars and RMO's
2019 | Dr Gary Wang, Registrar, FMC – Prostate Cancer Outcomes in men diagnosed with Gleason 10 pathology |
2018 | Dr Gary Wang, Registrar, FMC – Prostate Cancer Outcomes in men aged 90 and over at diagnosis |
2017 | Dr Diwei Lin, Registrar, RGH –Urethral length and continence post RALP |
2017 | Dr Tom Cundy, Registrar, RGH – Paediatric Urologic Cancers in Australia |
PhD Students
2016-2019 | Dr Adel Aref, PhD Candidate, University of Adelaide, Discipline of Medicine, Freemasons Foundation for Men’s Health Centre. Supervisors: Lisa Butler, Andrew Vincent, Gary Wittert, M O’Callaghan, Andrew Hoy. This thesis received a Dean’s letter of commendation. |
Master Students
2020 | Dr Jake Tempo, MSurg Candidate, Flinders University Supervisors: M O’Callaghan, D Watson |
2020 | Dr Georgina Williams, MSurg Candidate, Flinders University Supervisors: M O’Callaghan, D Watson |
2019 - 2021 | Dr Matthew Borg, MSc candidate, University of Adelaide Supervisors: A Vincent, M O’Callaghan |
2019 | Dr Athul John, MPhil (Surg) Candidate, University of Adelaide. Supervisors: M O’Callaghan, L Selth, R Catterwell |
2018 | Dr Rowan David, Masters of Surgery Candidate, Flinders University, Discipline of Surgery. Supervisors: M O’Callaghan, D Watson, J Lee. |
2018 - 2019 | Dr Minh Tran, Masters of Surgical Sciences, The University of Edinburgh, Edinburgh Medical School. Research Supervisor: M O’Callaghan |
Honours Students
2018 | Ms Mrunal Hiwase– Prediction of Metastatic Prostate Cancer (University of Adelaide) – Supervisors: M O’Callaghan, A Vincent. First Class honours |
2018 | Stamati Morias – Mentor – Honors Radiation Therapy – University of South Australia Supervisors: Michala Short, Elizabth Buckley, Kerri Beckmann |
Undergraduate Students
2020 | Ms Meg Prosser, Radiation Therapy Student, University of South Australia, Summer Vacation Research Scholarship, Freemason’s Foundation for Men’s Health – Bowel Health after Radiation Treatment of Prostate Cancer. |
2018 | Mr Adam Hamilton, 3rd Year Bachelor of Mathematical Studies, University of Adelaide, Summer Vacation Research Scholarship, Freemason’s Foundation for Men’s Health – Hidden mathematics in genitourinary anatomy. Co-supervisors Dr Thomas Cundy, Prof Tony Roberts, Dr Mark Sparnon |
Classes
2017 - present | Southern Adelaide Local Health Network Urology Journal Club. Held bi-monthly for urology fellows, registrars, resident medical officers, students and clinicians. This journal club reviews, critiques and discusses the latest publications in the urology literature. Paper summaries and critiques are published at: www.wikijournalclub.org |
-
Current Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2021 Principal Supervisor Pathological parameters of positive surgical margins Doctor of Philosophy Doctorate Part Time Dr Athul Francis John -
Past Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2016 - 2019 Co-Supervisor Defining the Role of Lipids and Metabolic Factors as Risk Factors for Prostate Cancer Incidence and Aggressiveness Doctor of Philosophy Doctorate Full Time Dr Adel Tahseen Abdelhamid Aref
-
Committee Memberships
Date Role Committee Institution Country 2020 - ongoing Member Steering Committee of the South Australian Clinical Cancer Registry South Australian Clinical Cancer Australia 2019 - ongoing Member Radiation Oncology Quality Indicator Working Group Prostate Cancer Outcomes Registry Australia and New Zealand Australia 2018 - ongoing Member Prostate Cancer Symposium South Australian Prostate Cancer Clinical Outcomes Collaborative Australia 2017 - ongoing Member Prostate Cancer Symposium South Australian Prostate Cancer Clinical Outcomes Collaborative Australia 2017 - 2017 Chair Clinical Registries Oral Presentation Session, Flinders Health Research Week, Flinders Medical Centre Australia 2017 - ongoing Member Surgical Quality Indicator Working Group Prostate Cancer Outcomes Registry Australia and New Zealand Australia -
Memberships
Date Role Membership Country 2014 - ongoing Member Urological Society of Australia and New Zealand, Australia 2014 - ongoing Member Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group Australia 2014 - ongoing Member Freemasons Foundation Centre for Men’s Health Australia
Connect With Me
External Profiles